Kontoyiannis D - Search Results

1

Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease.

Kontoyiannis D, Boulougouris G, Manoloukos M, Armaka M, Apostolaki M, Pizarro T, Kotlyarov A, Forster I, Flavell R, Gaestel M, Tsichlis P, Cominelli F, Kollias G. Kontoyiannis D, et al. J Exp Med. 2002 Dec 16;196(12):1563-74. doi: 10.1084/jem.20020281. J Exp Med. 2002. PMID: 12486099 Free PMC article.

2

Functional genetic and genomic analysis of modeled arthritis.

Douni E, Armaka M, Kontoyiannis DL, Kollias G. Douni E, et al. Adv Exp Med Biol. 2007;602:33-42. doi: 10.1007/978-0-387-72009-8_4. Adv Exp Med Biol. 2007. PMID: 17966385 Review. No abstract available.

3

Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases.

Armaka M, Apostolaki M, Jacques P, Kontoyiannis DL, Elewaut D, Kollias G. Armaka M, et al. Among authors: kontoyiannis dl. J Exp Med. 2008 Feb 18;205(2):331-7. doi: 10.1084/jem.20070906. Epub 2008 Feb 4. J Exp Med. 2008. PMID: 18250193 Free PMC article.

4

Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease.

Apostolaki M, Manoloukos M, Roulis M, Wurbel MA, Müller W, Papadakis KA, Kontoyiannis DL, Malissen B, Kollias G. Apostolaki M, et al. Gastroenterology. 2008 Jun;134(7):2025-35. doi: 10.1053/j.gastro.2008.02.085. Epub 2008 Mar 5. Gastroenterology. 2008. PMID: 18439426

5

Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments.

Kollias G, Kontoyiannis D. Kollias G, et al. Among authors: kontoyiannis d. Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):315-21. doi: 10.1016/s1359-6101(02)00019-9. Cytokine Growth Factor Rev. 2002. PMID: 12220546 Review.

6

Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Kontoyiannis D, et al. Immunity. 1999 Mar;10(3):387-98. doi: 10.1016/s1074-7613(00)80038-2. Immunity. 1999. PMID: 10204494 Free article.

7

On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Kollias G, Douni E, Kassiotis G, Kontoyiannis D. Kollias G, et al. Among authors: kontoyiannis d. Immunol Rev. 1999 Jun;169:175-94. doi: 10.1111/j.1600-065x.1999.tb01315.x. Immunol Rev. 1999. PMID: 10450517 Review.

8

The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease.

Kollias G, Douni E, Kassiotis G, Kontoyiannis D. Kollias G, et al. Among authors: kontoyiannis d. Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I32-9. doi: 10.1136/ard.58.2008.i32. Ann Rheum Dis. 1999. PMID: 10577971 Free PMC article. Review.

9

Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor.

Kontoyiannis D, Kollias G. Kontoyiannis D, et al. Eur J Immunol. 2000 Jul;30(7):2038-47. doi: 10.1002/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K. Eur J Immunol. 2000. PMID: 10940893 Free article.

10

Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology.

Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M, Davis R, Flavell R, Kollias G. Kontoyiannis D, et al. EMBO J. 2001 Jul 16;20(14):3760-70. doi: 10.1093/emboj/20.14.3760. EMBO J. 2001. PMID: 11447117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters